TJPC(SH:600488) Jin Rong Jie·2025-08-27 19:22Group 1 - The stock price of Tianyao Pharmaceutical closed at 4.31 yuan on August 27, down 0.19 yuan or 4.22% from the previous trading day [1] - The company operates in the chemical pharmaceutical industry, focusing on the research, production, and sales of steroid hormone and amino acid raw materials and formulations [1] - Tianyao Pharmaceutical is recognized as a national high-tech enterprise and is a global leader in amino acid raw material manufacturing [1] Group 2 - On the evening of August 27, Tianyao Pharmaceutical announced that its subsidiary Tianyao Heping received approval from the National Medical Products Administration for the registration certificate of Difluprednate Eye Drops, which is the first generic version in China [1] - The drug is primarily used for treating inflammation and pain related to eye surgeries, with a cumulative R&D investment of approximately 53.27 million yuan [1] - According to IQVIA data, the global sales for this drug are projected to be 33 million USD in 2023 and 24 million USD in 2024 [1] Group 3 - On August 27, the net inflow of main funds into Tianyao Pharmaceutical was 7.69 million yuan, accounting for 0.16% of the circulating market value [1] - Over the past five days, the net inflow of main funds totaled 34.99 million yuan, representing 0.74% of the circulating market value [1]